Cargando…
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells
Multiple sclerosis (MS) is an inflammatory autoimmune disease characterized by imbalanced immune regulatory networks, and MS patient-derived T effector cells are inefficiently suppressed through regulatory T cells (Treg), a phenomenon known as Treg resistance. In the current study we investigated T...
Autores principales: | Trinschek, Bettina, Luessi, Felix, Gross, Catharina C., Wiendl, Heinz, Jonuleit, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519953/ https://www.ncbi.nlm.nih.gov/pubmed/26193267 http://dx.doi.org/10.3390/ijms160716330 |
Ejemplares similares
-
Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013) -
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013) -
Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells
por: Schlöder, Janine, et al.
Publicado: (2017) -
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016) -
Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)